Effects of oral administration of PGE2 on gastric secretion and experimental peptic ulcerations.
D000818:Animals; D002021:Buffers; D002415:Cats; D004386:Duodenum / Q000187:drug effects; D005750:Gastric Juice / Q000378:metabolism; D005753:Gastric Mucosa / Q000187:drug effects / Q000378:metabolism; D006168:Guinea Pigs; D006854:Hydrocortisone; D006863:Hydrogen-Ion Concentration; D007275:Injections, Intravenous; D008026:Ligation; D008297:Male; D010418:Pentagastrin; D010434:Pepsin A / Q000037:antagonists & inhibitors; D010437:Peptic Ulcer / Q000139:chemically induced / Q000517:prevention & control; D010640:Phenothiazines; D011453:Prostaglandins / Q000008:administration & dosage / Q000494:pharmacology; D011708:Pylorus / Q000502:physiology; D051381:Rats; D012110:Reserpine
D002021:Buffers; D010640:Phenothiazines; D011453:Prostaglandins; D012110:Reserpine; D010434:Pepsin A; D010418:Pentagastrin; D006854:Hydrocortisone